In Response to Fogarty Et Al. And Why Adjuvant Whole Brain Radiotherapy Is Not Recommended Routinely

BMC Cancer- United Kingdom

doi 10.1186/s12885-017-3672-z

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC


Related search